APA (7th ed.) Citation

Elbadawi, M., Boulos, J. C., Dawood, M., Zhou, M., Gul, W., ElSohly, M. A., . . . Efferth, T. (2023). The novel artemisinin imer Isoniazide ELI-XXIII-98-2 induces c-MYC inhibition, DNA damage, and autophagy in leukemia cells. Pharmaceutics, 15(4), . https://doi.org/10.3390/pharmaceutics15041107

Chicago Style (17th ed.) Citation

Elbadawi, Mohamed, Joelle C. Boulos, Mona Dawood, Min Zhou, Waseem Gul, Mahmoud A. ElSohly, Sabine Klauck, and Thomas Efferth. "The Novel Artemisinin Imer Isoniazide ELI-XXIII-98-2 Induces C-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells." Pharmaceutics 15, no. 4 (2023). https://doi.org/10.3390/pharmaceutics15041107.

MLA (9th ed.) Citation

Elbadawi, Mohamed, et al. "The Novel Artemisinin Imer Isoniazide ELI-XXIII-98-2 Induces C-MYC Inhibition, DNA Damage, and Autophagy in Leukemia Cells." Pharmaceutics, vol. 15, no. 4, 2023, https://doi.org/10.3390/pharmaceutics15041107.